Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis - Quiz - MDSpire

Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis

  • By

  • Jingqiang Xie

  • Chunying Pu

  • Mingyue Sun

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Related Content